Orkla ASA ORK
Oslo Børs · Consumer Defensive · Packaged Foods
Keep this stock on your watchlist and set email alerts for prices, reports and important announcements where available.
Annual accounts for Orkla
| NOK million | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | 58,391 | 67,797 | 69,254 | 71,547 |
| EBITDA | 10,177 | 11,060 | 12,070 | 12,596 |
| Net income | 5,019 | 5,196 | 6,057 | 11,473 |
| Balance sheet | ||||
| Equity | 41,686 | 45,267 | 48,044 | 48,664 |
| Total debt | 18,771 | 20,488 | 18,161 | 16,463 |
| Cash | 1,180 | 779 | 1,454 | 1,918 |
| Net debt | 17,591 | 19,709 | 16,707 | 14,545 |
| Ratios and per share | ||||
| EBITDA margin | 17.4% | 16.3% | 17.4% | 17.6% |
| Profit margin | 8.6% | 7.7% | 8.7% | 16.0% |
| Return on equity | 12.0% | 11.5% | 12.6% | 23.6% |
| Earnings/share (NOK) | 5.03 | 5.21 | 6.06 | 11.59 |
| Book value/share (NOK) | 41.81 | 45.37 | 48.10 | 49.16 |
| Shares outstanding (M) | 997 | 998 | 999 | 990 |
From the annual statements (Yahoo Finance), in the currency the company reports in. Per-share figures use the shares at the year end. Charts and annual figures →
Quarterly figures from the reports
BetaFrom the company's own reports: 58 reports read by AI, every figure checked against the report's page and arithmetic.
Source: the Q3 2026 report, page 16, published 2026-11-06.
| Quarter | Revenue | Operating profit | Profit | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q3 2026 | 17,541 | 1,588 | 1,737 | 1.80 | … | Q3 2026, p. 16 |
| Q2 2026 | 16,699 | 1,871 | 1,668 | 1.70 | … | Second quarter and first half year 2026, p. 18 |
| Q1 2026 | 17,401 | 31,736 | 1,689 | 1.72 | … | First quarter 2026, p. 18 |
| Q4 2025 | 18,775 | 1,826 | 1,888 | 1.90 | … | Fourth quarter 2025, p. 19 |
| Q3 2025 | 69,254 | 7,142 | 6,057 | 6.07 | … | Third quarter 2025, p. 18 |
| Q2 2025 | 17,650 | 1,872 | 6,221 | 6.24 | … | Second quarter and first half year 2026, p. 18 |
| Q1 2025 | 17,176 | 1,750 | 1,793 | 1.80 | … | First quarter 2025, p. 18 |
| Q4 2024 | 18,793 | 1,826 | 1,360 | 1.36 | … | Fourth quarter 2024, p. 20 |
| Q3 2024 | 67,797 | 6,234 | 5,196 | 5.21 | … | Third quarter 2024, p. 20 |
| Q2 2024 | 67,797 | 6,234 | 5,196 | 5.21 | … | First half 2024, p. 20 |
| Q1 2024 | 17,107 | – | 1,469 | 1.47 | … | First quarter 2024, p. 19 |
| Q4 2023 | −33,275 | 1,266 | −2,648 | −2.65 | … | Third quarter 2023, p. 20 |
Amounts in NOK million, EPS in NOK. Each quarter as first reported, as a backtest would have seen it. Adjusted EPS (without one-off items) is shown once the one-off items have been checked against the companies' own adjusted figures.
One-off items in the reports
- 2026-09-30 Reversal of remaining Sapa provision recognised as income under discontinued operations: +287.0 NOK million (Q3 2026, p. 27)
- 2026-09-30 Write-downs mainly of goodwill and trademarks in Healthspan (Orkla Health): −283.0 NOK million (Q3 2026, p. 4)
- 2026-09-30 Loss on sale of Eisunion in Orkla Food Ingredients: −146.0 NOK million (Q3 2026, p. 20)
- 2026-06-30 Loss on sale of a joint venture in China by Orkla House Care, adjusted out of earnings per share (adj.): −10.0 NOK million (Q2 2026 and first half 2026, p. 21)
- 2026-06-30 Net other income and expenses, Q2 2026 (mainly gain on sale of Nói Síríus, less costs for the New York Pizza incentive programme settlement, restructuring in Orkla Foods and Snacks, and M&A costs). Excluded from EBIT (adj.).: +97.0 NOK million (Q2 2026 and first half 2026, p. 5)
- 2026-06-30 Gain on sale of Nói-Síríus HF by Orkla Snacks, reported in Other income and expenses; non-taxable: +194.0 NOK million (Q2 2026 and first half 2026, p. 21)
- 2026-03-31 Other income and expenses (net costs), mainly M&A costs and restructuring projects in Orkla Foods and Orkla Health; excluded from EBIT (adj.): −45.0 NOK million (Q1 2026, p. 5)
- 2026-03-31 Other income and expenses after tax and non-controlling interests, adjusted out of earnings per share (adj.): −38.0 NOK million (Q1 2026, p. 24)
Found by AI and still being validated: hover for the report's own words.
Sign in for free to open each report on the page a figure comes from.
Extracted by an AI model from the reports and can be wrong. Not investment advice.
Key figures
| P/E | 8.9 |
| P/B | 2.1 |
| EV / EBITDA | 9.2 |
| Net debt / EBITDA | 1.2 |
| Return on equity | 23.6% |
| Profit margin | 16.0% |
| Beta 1Y | 0.11 |
| Revenue growth 1Y | +3.3% |
| Revenue CAGR 3Y | +7.0% |
| Earnings/share CAGR 3Y | +32.1% |
| ROE avg. 3Y | 15.9% |
Ratios use the latest annual report that was public 90 days after the year end.
Dividends per share (NOK)
| 2026 | 6.00 |
| 2025 | 10.00 |
| 2024 | 6.00 |
| 2023 | 3.00 |
| 2022 | 3.00 |
Not investment advice. Figures may contain errors from the data source.